Candida species | Elderly patients (≥65 years, n =63) | Younger patients (16-60 years, n =84) |
---|---|---|
Candida albicans | 27/63 (42.9) | 31/84 (36.9) |
 Fluconazole | 1/27 (3.7) | 1/31 (3.2) |
 Voriconazole | 1/27 (3.7) | 0/31 (0) |
 Caspofungin | 0/27 (0) | 0/31 (0) |
Non- C. albicans species | 36/63 (57.1) | 53/84 (63.1) |
 Fluconazole | 11/36 (30.6) | 8/53 (15.1) |
 Voriconazole | 3/36 (8.3) | 2/53 (3.8) |
 Caspofungin | 0/36 (0) | 0/53 (0) |
Candida tropicalis | 16/63 (25.4) | 19/84 (22.6) |
 Fluconazole | 4/16 (25.0) | 1/19 (5.3) |
 Voriconazole | 2/16 (12.5) | 1/19 (5.3) |
 Caspofungin | 0/16 (0) | 0/19 (0) |
Candida parapsilosis | 9/63 (14.3) | 17/84 (20.2) |
 Fluconazole | 2/9 (22.2) | 1/17 (5.9) |
 Voriconazole | 0/9 (0.0) | 0/17 (0) |
 Caspofungin | 0/9 (0) | 0/17 (0) |
Candida glabrata | 7/63 (11.1) | 9/84 (10.7) |
 Fluconazole | 2/7 (28.6) | 0/9 (0) |
 Voriconazole | 1/7 (14.3) | 0/9 (0) |
 Caspofungin | 0/7 (0) | 0/9 (0) |
Candida krusei a | 3/63 (4.8) | 6/84 (7.1) |
 Fluconazole | 3/3 (100.0) | 6/6 (100.0) |
 Voriconazole | 0/3 (0) | 1/6 (16.7%) |
 Caspofungin | 0/3 (0) | 0/6 (0) |
Othera | 1/63 (1.6)* | 2/84 (2.4) †|
 Fluconazole | 0/1 (0) | 0/2 (0) |
 Voriconazole | 0/1 (0) | 0/2 (0) |
 Caspofungin | 0/1 (0) | 0/2 (0) |